RAD reduces compensatory renal graft hypertrophy in a rat model of chronic rejection.
Viklický
O
O
Department of Nephrology, University Hospital Essen, Essen, Germany.
Müller
V
V
Zou
H
H
Szabó
A
A
Vitko
S
S
Heemann
U
U
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D016572:Cyclosporine / Q000627:therapeutic use; D004195:Disease Models, Animal; D000068338:Everolimus; D005923:Glomerulosclerosis, Focal Segmental / Q000517:prevention & control; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006984:Hypertrophy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology*; D009929:Organ Size / Q000187:drug effects; D011507:Proteinuria; D051381:Rats; D011916:Rats, Inbred F344; D011917:Rats, Inbred Lew; D020123:Sirolimus / Q000031:analogs & derivatives / Q000494:pharmacology*
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000068338:Everolimus; D020123:Sirolimus